Articles with public access mandates - Maia KayalLearn more
Not available anywhere: 6
Treatment of pouchitis, Crohn's disease, cuffitis, and other inflammatory disorders of the pouch: consensus guidelines from the International Ileal Pouch Consortium
B Shen, GS Kochhar, DT Rubin, SV Kane, U Navaneethan, CN Bernstein, ...
The Lancet Gastroenterology & Hepatology 7 (1), 69-95, 2022
Mandates: US National Institutes of Health
An expert consensus to standardise clinical, endoscopic and histologic items and inclusion and outcome criteria for evaluation of pouchitis disease activity in clinical trials
R Sedano, C Ma, RK Pai, G D'Haens, L Guizzetti, LM Shackelton, ...
Alimentary Pharmacology & Therapeutics 53 (10), 1108-1117, 2021
Mandates: US National Institutes of Health
Clinical Challenge: Proactive Precise Management of Active Ulcerative Colitis During Pregnancy—Advantages of Point-of-Care Intestinal Ultrasound and Therapeutic Drug Monitoring
ZS Gottlieb, M Dolinger, M Kayal, BB Rao, A Bhattacharya, MC Dubinsky, ...
Digestive Diseases and Sciences 67 (8), 3557-3561, 2022
Mandates: US National Institutes of Health
Changes in Therapy Are Not Associated With Increased Remission in Patients With Crohn’s Disease of the Pouch
M Kayal, P Deepak, P Beniwal-Patel, L Raffals, M Dubinsky, S Chang, ...
Official journal of the American College of Gastroenterology| ACG, 10.14309, 2022
Mandates: US National Institutes of Health
Besting the biologics: vancomycin monotherapy for ulcerative colitis management in patients with primary sclerosing cholangitis
T Ahmed, M Kayal, D Hashem, RC Ungaro
Digestive Diseases and Sciences 68 (4), 1118-1120, 2023
Mandates: US National Institutes of Health
Pouch Body Anastomotic Ulcerations Are Not Associated With an Increased Risk of Pouchitis
M Hossain, M Plietz, S Khaitov, P Sylla, A Greenstein, MC Dubinsky, ...
Inflammatory Bowel Diseases, izad172, 2023
Mandates: US National Institutes of Health
Available somewhere: 24
L-dex ratio in detecting breast cancer-related lymphedema: reliability, sensitivity, and specificity
MR Fu, CM Cleland, AA Guth, M Kayal, J Haber, F Cartwright, R Kleinman, ...
Lymphology 46 (2), 85, 2013
Mandates: US National Institutes of Health
Sex-based differences in inflammatory bowel diseases: a review
SD Rustgi, M Kayal, SC Shah
Therapeutic advances in gastroenterology 13, 1756284820915043, 2020
Mandates: US Department of Veterans Affairs
Ulcerative colitis: current and emerging treatment strategies
M Kayal, S Shah
Journal of clinical medicine 9 (1), 94, 2019
Mandates: US National Institutes of Health
Inflammatory pouch conditions are common after ileal pouch anal anastomosis in ulcerative colitis patients
M Kayal, M Plietz, A Rizvi, M Radcliffe, A Riggs, C Yzet, E Tixier, P Trivedi, ...
Inflammatory bowel diseases 26 (7), 1079-1086, 2020
Mandates: US National Institutes of Health
Endoscopic activity in asymptomatic patients with an ileal pouch is associated with an increased risk of pouchitis
M Kayal, M Plietz, M Radcliffe, A Rizvi, C Yzet, E Tixier, RP Hirten, ...
Alimentary pharmacology & therapeutics 50 (11-12), 1189-1194, 2019
Mandates: US National Institutes of Health
Disability in inflammatory bowel disease patients is associated with race, ethnicity and socio‐economic factors
M Agrawal, S Cohen‐Mekelburg, M Kayal, J Axelrad, J Galati, B Tricomi, ...
Alimentary pharmacology & therapeutics 49 (5), 564-571, 2019
Mandates: US National Institutes of Health
Emergent colectomy rates decreased while elective ileal pouch rates were stable over time: a nationwide inpatient sample study
M Kayal, A Saha, P Poojary, S Paramsothy, R Hirten, L Cohen, ...
International journal of colorectal disease 34, 1771-1779, 2019
Mandates: US National Institutes of Health
Early Pouchitis Is Associated With Crohn’s Disease–like Pouch Inflammation in Patients With Ulcerative Colitis
M Kayal, D Kohler, M Plietz, S Khaitov, P Sylla, A Greenstein, ...
Inflammatory Bowel Diseases 28 (12), 1821-1825, 2022
Mandates: US National Institutes of Health
Recycling of precolectomy anti-tumor necrosis factor agents in chronic pouch inflammation is associated with treatment failure
M Kayal, T Lambin, M Plietz, A Rizvi, M Radcliffe, S Khaitov, P Sylla, ...
Clinical Gastroenterology and Hepatology 19 (7), 1491-1493. e3, 2021
Mandates: US National Institutes of Health
Net remission rates with biologic treatment in Crohn’s disease: a reappraisal of the clinical trial data
M Kayal, RC Ungaro, G Bader, JF Colombel, WJ Sandborn, C Stalgis
Clinical Gastroenterology and Hepatology 21 (5), 1348-1350, 2023
Mandates: US National Institutes of Health
Ileal pouch anal anastomosis for the management of ulcerative colitis is associated with significant disability
M Kayal, RC Ungaro, A Riggs, K Kamal, M Agrawal, S Cohen-Mekelburg, ...
Clinical Gastroenterology and Hepatology 20 (4), e761-e769, 2022
Mandates: US National Institutes of Health
Development of the endoscopic pouch score for assessment of inflammatory conditions of the pouch
EL Barnes, MD Long, L Raffals, K Isaacs, RW Stidham, HH Herfarth, ...
Clinical Gastroenterology and Hepatology 21 (6), 1663-1666. e3, 2023
Mandates: US National Institutes of Health
Disease and treatment patterns among patients with pouch-related conditions in a cohort of large tertiary care inflammatory bowel disease centers in the United States
EL Barnes, L Raffals, MD Long, G Syal, M Kayal, A Ananthakrishnan, ...
Crohn's & Colitis 360 2 (3), otaa039, 2020
Mandates: US National Institutes of Health
Treatment patterns and standardized outcome assessments among patients with inflammatory conditions of the pouch in a prospective multicenter registry
EL Barnes, P Deepak, P Beniwal-Patel, L Raffals, M Kayal, M Dubinsky, ...
Crohn's & Colitis 360 4 (3), otac030, 2022
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program